Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
acquisition entities : Petra acquisition inc. save search
Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
Published: 2024-03-13 (Crawled : 14:30) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: -4.81%
H: 0.34%
C: -12.46%
presentation care
Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
Published: 2024-03-12 (Crawled : 14:30) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 0.0%
H: 0.0%
C: -7.14%
conference
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
Published: 2024-03-04 (Crawled : 16:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 0.82%
H: 0.0%
C: -7.08%
first study
Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
Published: 2024-02-13 (Crawled : 18:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 1.45%
H: 15.36%
C: 7.14%
conference presentation international care
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
Published: 2024-02-01 (Crawled : 12:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: -59.77%
H: 2.82%
C: -10.17%
million offering
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
Published: 2024-01-30 (Crawled : 15:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: -10.47%
H: 2.98%
C: -31.64%
conference international care
Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024
Published: 2024-01-23 (Crawled : 15:30) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 0.26%
H: 7.81%
C: -21.59%
Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference
Published: 2023-10-04 (Crawled : 14:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 3.89%
H: 0.0%
C: -3.89%
conference
Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors
Published: 2023-10-02 (Crawled : 14:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 4.44%
H: 0.0%
C: -1.43%
Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress
Published: 2023-05-22 (Crawled : 20:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 6.31%
H: 10.17%
C: 0.85%
financial results
Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board
Published: 2023-03-13 (Crawled : 14:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 1.16%
H: 0.57%
C: -0.86%
Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference
Published: 2023-03-06 (Crawled : 15:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: -0.46%
H: 0.46%
C: -1.39%
conference
Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering
Published: 2023-02-13 (Crawled : 22:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 1.75%
H: 0.69%
C: -1.38%
offering
Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering
Published: 2023-02-09 (Crawled : 22:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: -23.88%
H: 3.68%
C: -32.35%
offering
Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300
Published: 2023-02-07 (Crawled : 15:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 11.05%
H: 11.83%
C: -30.35%
preclinical biomarker
Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review
Published: 2022-12-05 (Crawled : 13:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 2.88%
H: 1.6%
C: -5.28%
SNCE | $5.75 0.26% 49K
|
|
| O: 3.33%
H: 8.03%
C: -1.6%
VINC | $0.8967 -5.63% -5.97% 530K
|
|
| O: -4.17%
H: 7.25%
C: 1.45%
FUSN | $21.24 0.0% 330K
|
Health Technology
|
| O: 10.57%
H: 0.0%
C: -5.98%
DFFN 4 | $6.6 11.68% -34.32% 350K
|
Health Technology
|
| O: 0.0%
H: 9.84%
C: 6.89%
pharmaceuticals review positive
Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-Dealing
Published: 2022-12-05 (Crawled : 12:00) - globenewswire.com
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 2.88%
H: 1.6%
C: -5.28%
SNCE | $5.75 0.26% 49K
|
|
| O: 3.33%
H: 8.03%
C: -1.6%
VINC | $0.8967 -5.63% -5.97% 530K
|
|
| O: -4.17%
H: 7.25%
C: 1.45%
FUSN | $21.24 0.0% 330K
|
Health Technology
|
| O: 10.57%
H: 0.0%
C: -5.98%
DFFN 4 | $6.6 11.68% -34.32% 350K
|
Health Technology
|
| O: 0.0%
H: 9.84%
C: 6.89%
pharmaceuticals positive
Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model
Published: 2022-11-18 (Crawled : 00:20) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 5.93%
H: 2.84%
C: -5.27%
preclinical biomarker
Revelation Biosciences Inc. Announces Positive Results in Preclinical Model of Acute and Chronic Kidney Disease
Published: 2022-10-25 (Crawled : 16:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 28.83%
H: 55.86%
C: 27.76%
disease preclinical kidney positive results
Revelation Biosciences Inc. and Vanderbilt University Enter Exclusive Worldwide License Agreement
Published: 2022-10-06 (Crawled : 12:00) - biospace.com/
REVB | $2.24 4.19% 10.75% 97K
|
|
| O: 26.23%
H: 12.91%
C: -9.34%
license agreement
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.